[quote Lostinacloud]@strangeshapedpotato annoyingly I misquoted that sars-cov1 is known as swine flu. I did of course mean the coronavirus SARS.
The rest is correct[/quote]
OK - so what I think you are actually referring to (God i've seen this study misquoted so much recently) is about the antibodies of a single SARS-1 survivor, that were found to kill other coronaviruses.
This is about the nature of immune systems and I addressed this higher up the thread.
When shown an antigen, your immune picks the targets, which can be any of multiple possible attack sites on a virus, esp a large complex one like SARS.
With this particular individual, their immune system seems to have picked a site common to many (if not all?) coronaviruses. If a vaccine could be produced able to produce these antibodies in everyone, the world could breathe a huge sigh of relief. However, that's a challenge.
What you seem to have believed is that this response is true of all SARS-1 survivors. Nope - just the one.
Side note - this is why vaccine efficiency varies with variants and is not a works/doesn't work binary situation.
Shown the same target 100 different people's immune systems will choose different sites of attack. Some will pick targets common to multiple variants. Others will pick targets specific to a single variant.
Depending on how many immune responses are variant specific will determine how much efficacy is lost when the virus mutates.